Project Grant K99CA307136
Award Date 5/1/26
Completion Date 4/30/28
Dollars Obligated $132K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- Federal Project Grant Award Summary Award Details: The National Cancer Institute (NCI), under the Cancer Research Manpower program (CFDA 93.398), awarded $150,104 to The University of Texas MD Anderson Cancer Center on December 18, 2025, with a completion date of June 2, 2028. Products and Services: This project grant supports the development of computational tools and analytical approaches to map the evolutionary trajectories of complex genome rearrangements in cancer. The award funds two...
- Federal Grant Award Summary The National Cancer Institute awarded The University of Texas MD Anderson Cancer Center a $420,400 Project Grant under the Cancer Treatment Research program (CFDA 93.395) effective August 1, 2025, through July 31, 2027. This award supports exploratory studies investigating cellular resistance mechanisms to second-generation MTA-cooperative PRMT5 inhibitors (MTA:PRMT5I) in MTAP-loss tumors. The research addresses a critical clinical challenge whereby 40-60% of patients...
- Federal Grant Award Summary The University of Texas MD Anderson Cancer Center received a $449,625 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on September 15, 2025, with completion targeted for July 31, 2030. This award funds the development of novel statistical methods to delineate spatial and temporal patterns of cell-cell interactions (CCIs) in spatial transcriptomics (ST)...
- Federal Project Grant Award Summary The University of Texas MD Anderson Cancer Center received a $192,240 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective August 1, 2025, through July 31, 2030. This award funds research to decode mosaic chromosomal alterations (MCAs) in lymphoid malignancy risk and outcomes. The project delivers comprehensive scientific investigation into somatic megabase-scale alterations detectable...
- Federal Project Grant Award Summary The University of Texas MD Anderson Cancer Center received a $421,685 project grant from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395), awarded August 1, 2025, with a completion date of July 31, 2027. This award supports research investigating the LIFR-LCN2 pathway as a novel mechanism of immune suppression in hepatocellular carcinoma (HCC). The research aims to elucidate how loss of LIFR upregulates LCN2, leading to...
- Federal Grant Award Summary The University of Texas MD Anderson Cancer Center received a $680,129 Project Grant from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), effective April 1, 2026 through March 31, 2031. This award supports the development of drug-loaded degradable biopolymeric scaffolds designed to augment preoperative liver growth in cancer patients undergoing surgical resection. The research addresses critical clinical challenges...
- Federal Project Grant Award Summary The University of Texas MD Anderson Cancer Center received a $510,671 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded May 1, 2026, with a completion date of April 30, 2031. This award funds research into the functional characterization of lineage plasticity in cholangiocarcinoma (CCA), a highly aggressive bile duct cancer. The project will deliver a comprehensive functional...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant of $616,715 to The University of Texas MD Anderson Cancer Center, with an award date of August 11, 2025 and completion date of July 31, 2030. This award supports research under the Cancer Treatment Research program (CFDA 93.395), which develops and evaluates improved methods of cancer treatment through fundamental and applied laboratory and clinical research. The funded research centers on the...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded MD Anderson Cancer Center a $2.46 million project grant under the Cancer Treatment Research program (CFDA 93.395) effective August 18, 2025, through July 31, 2030. The INHANCE (Imaging Innovation for Head and Neck Cancer Evaluation & Treatment Delivery) initiative develops advanced imaging and computational image analysis methodologies to predict, detect, prevent, and manage therapy-related normal tissue injury in head...
- Federal Project Grant Award Summary The National Cancer Institute awarded a $421,685 Project Grant under the Cancer Biology Research program (CFDA 93.396) to The University of Texas MD Anderson Cancer Center, effective August 1, 2025, through July 31, 2027. This award supports pan-cancer analysis of convergent immunoglobulins from tumor-infiltrating B cells (TIL-B), with the primary deliverable being the identification and characterization of shared B cell receptors (BCR) and antibodies across...